Xtx Topco LTD Adagio Therapeutics, Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	N/A	15,376 Added 68.15%	37,938 $125,000
Q1 2024 May 13, 2024	BUY	N/A	22,562 New	22,562 $74,000
Q3 2023 Nov 13, 2023	BUY	N/A	18,940 New	18,940 $62,000
Q1 2022 May 13, 2022	SELL	$3.81 - $10.77 $78,809 - $222,777	-20,685 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$6.35 - $47.04 $131,349 - $973,022	20,685 New	20,685 $150,000

63.9M

2.3K

2.1K

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.